Cholestatic liver disease after small bowel transplantation failure in children.
Colomb
V
V
Department of Pediatric Gastroenterology, Hopital Necker-Enfants-Malades, Paris, France.
Goulet
O J
OJ
Revillon
Y
Y
Jan
D
D
Brousse
N
N
Rambaud
C
C
De Potter
S
S
Francois
B
B
Sarnacki
S
S
Ricour
C
C
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002779:Cholestasis / Q000453:epidemiology*; D006084:Graft Rejection / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007413:Intestinal Mucosa / Q000473:pathology; D007421:Intestine, Small / Q000473:pathology / Q000637:transplantation*; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use; D010289:Parenteral Nutrition, Total; D011183:Postoperative Complications; D012778:Short Bowel Syndrome / Q000601:surgery / Q000628:therapy; D017211:Treatment Failure
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3